Tyco Urology Franchise Leaps Ahead With $3.2 Bil. Bard Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Tyco International will increase its total health care sales to about $7.6 bil. annually through acquisition of C.R. Bard for approximately $3.2 bil. in stock. Valued at nearly three times Bard's 2000 sales of $1.1 bil., the definitive agreement was announced May 30.